Adaptimmune Therapeutics (ADAP)
(Real Time Quote from BATS)
$1.14 USD
+0.05 (4.59%)
Updated Sep 9, 2024 10:08 AM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | 0.27 |
Last EPS Surprise | NA |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.24 |
Next Year | -0.63 |
EPS (TTM) | -0.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 22.05M | 20.53M | 169.14M | 57.26M |
# of Estimates | 2 | 3 | 3 | 3 |
High Estimate | 27.20M | 30.70M | 191.80M | 78.18M |
Low Estimate | 16.90M | 10.80M | 154.01M | 41.60M |
Year ago Sales | 7.32M | 0.23M | 60.28M | 169.14M |
Year over Year Growth Est. | 201.23% | 8,826.96% | 180.58% | -66.15% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.12 | -0.24 | -0.63 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | -0.24 | -0.12 | -0.30 | -0.66 |
High Estimate | -0.10 | -0.07 | -0.09 | -0.52 |
Low Estimate | -0.24 | -0.17 | -0.30 | -0.75 |
Year ago EPS | -0.20 | -0.24 | -0.63 | -0.24 |
Year over Year Growth Est. | 15.00% | 50.00% | 61.90% | -164.58% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 4 | 2 |
Up Last 60 Days | 2 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 2 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.12 | -0.24 | -0.63 |
7 Days Ago | -0.17 | -0.12 | -0.24 | -0.63 |
30 Days Ago | -0.18 | -0.15 | -0.55 | -0.64 |
60 Days Ago | -0.18 | -0.14 | -0.61 | -0.59 |
90 Days Ago | -0.14 | -0.11 | -0.66 | -0.52 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.12 | -0.24 | -0.63 |
Zacks Consensus Estimate | -0.17 | -0.12 | -0.24 | -0.63 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.27 | -0.18 | -0.24 | -0.20 | NA |
Estimate | 0.00 | -0.16 | -0.12 | -0.20 | NA |
Difference | 0.27 | -0.02 | -0.12 | 0.00 | 0.03 |
Surprise | NA | -12.50% | -100.00% | 0.00% | -37.50% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more